The Food and Drug Administration (FDA) has cautioned the public not to buy or sell any health product that does not have FDA ...
OBI-902, targeting TROP2, gains FDA orphan drug status for cholangiocarcinoma, a rare cancer with poor prognosis and limited treatments. Orphan drug designation provides benefits like tax credits and ...
Poherdy can be dispensed as a substitute for Perjeta without requiring a prescription change from a health care provider.
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® ...
The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
The US FDA has approved the new drug application (NDA) for ziftomenib (Komzifti, formerly KO-539) in the treatment of ...
This official FDA action marks the culmination of a fifteen-year scientific and regulatory effort led by Professor Niazi, who has consistently argued that CES add no meaningful value to biosimilar ...
The ArrayRx program is free to any Arizona resident and offers savings of about 18% on brand-name prescriptions — and as much ...
Lamar Cook, a Springfield aide to Gov. Maura Healey charged with trafficking cocaine, can now post $75,000 cash bail after ...
You can cut your 2026 drug costs by using Medicare.gov to compare Part D plans based on total annual cost, not just monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback